ALEXANDRIA, Virginia, April 30 -- DECIPHERA PHARMACEUTICALS, LLC, Waltham, Massachusetts has been assigned a patent (No. US 11969415 B1, initially filed Nov. 22, 2023) developed by four inventors Michael D. Kaufman, Waltham, Massachusetts; Scott Bone, Bend, Oregon; Corey Bloom, Bend, Oregon; and Fred Jordan, Bend, Oregon, for "(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea." . . .